___

Why tech­nol­o­gy — not med­ica­tion — is the future of treat­ing old­er adults with depres­sion (McKnight’s Long-term Care News):

“The go-to treat­ment for many cas­es of depres­sion is med­ica­tion.

Unfor­tu­nate­ly, this treat­ment option can cause as many issues as the prob­lem it is try­ing to solve. Anti­de­pres­sants can put res­i­dents at greater risk of falls, neg­a­tive health com­pli­ca­tions and oth­er poor con­di­tions. Some stud­ies indi­cate that anti­de­pres­sants may not be effec­tive for most old­er Amer­i­cans. Read the rest of this entry »

_______

Heads-up: The Alzheimer’s Research & Pre­ven­tion Foun­da­tion (ARPF), a long­stand­ing sup­port­er of Sharp­Brains events and activ­i­ties, will be con­duct­ing its first Brain Longevi­ty Ther­a­py Train­ing — com­bin­ing pro­fes­sion­al devel­op­ment with a cer­ti­fi­ca­tion process — next week in Los Ange­les, CA (also with a livestream option).

And they are gen­er­ous­ly shar­ing dis­count codes (below) for inter­est­ed Sharp­Brains read­ers. Read the rest of this entry »

_______

The Alzheimer’s Research & Pre­ven­tion Foun­da­tion (ARPF), a long­stand­ing sup­port­er of Sharp­Brains events and activ­i­ties, will be con­duct­ing its first Brain Longevi­ty Ther­a­py Train­ing — com­bin­ing pro­fes­sion­al devel­op­ment with a cer­ti­fi­ca­tion process — dur­ing 4 days late Octo­ber in Los Ange­les, CA (also with a livestream option). And they are gen­er­ous­ly shar­ing dis­count codes for inter­est­ed Sharp­Brains read­ers (see below) Read the rest of this entry »

_______

Heads-up: The Alzheimer’s Research & Pre­ven­tion Foun­da­tion (ARPF) will be con­duct­ing its first Brain Longevi­ty Ther­a­py Train­ing — com­bin­ing pro­fes­sion­al devel­op­ment with a cer­ti­fi­ca­tion process — dur­ing 4 days late Octo­ber in Los Ange­les, CA (also with a livestream option). Read the rest of this entry »

——-

Being Super Busy May* Be Good For Your Brain (Smith­son­ian Mag­a­zine):

“There hasn’t been much sci­en­tif­ic research on busy­ness itself, although it’s some­thing that we talk about so often,” explains Sara Fes­ti­ni, a cog­ni­tive neu­ro­sci­en­tist at the Uni­ver­si­ty of Texas at Dal­las Cen­ter for Vital Longevi­ty, a co-author of the new research pub­lished this week Read the rest of this entry »